Harper Ellsworth Advertising, a Dallas-based full-service agency, has been named a finalist for the 2024 MM+M Awards, recognizing its work with Texas Radiotherapy in the category of "Use of Hospital or Healthcare Services Marketing." This nomination underscores the agency's commitment to excellence in healthcare marketing and communications and highlights the growing importance of effective marketing in public health.
The MM+M Awards are widely regarded as the gold standard in healthcare marketing, celebrating creativity and effectiveness. With over 90 judges evaluating hundreds of entries, being named a finalist is a significant achievement. The awards gala is scheduled for October 10, 2024, in New York City, where industry leaders will gather to honor outstanding work. As Larry Dobrow of MM+M noted, "The quality and sheer volume of work created by the medical marketing community are wonders to behold," reflecting the competitive nature of the field.
Kathlene Simmons, CEO of Harper Ellsworth, expressed excitement about the nomination, stating, "We are thrilled that our work for Texas Radiotherapy is selected as a finalist for such a prestigious award." She credited the collaborative effort of many talented individuals who worked together to raise awareness about prostate cancer. Melvin Strobbe, Project Creative Director, elaborated on the campaign's success, emphasizing the partnership with Texas Radiotherapy and the contributions of Dr. Matthew and Sara Cavey. The creative strategy focused on profiling actual patients, an approach Strobbe described as being "based on patient truth."
This nomination is particularly significant for the healthcare marketing industry. Harper Ellsworth's work aimed to increase awareness of prostate cancer among men, a crucial public health goal. The campaign's effectiveness in reaching and engaging its target audience demonstrates how marketing can drive better health outcomes by encouraging early detection and treatment. As a woman-owned business, Harper Ellsworth's success also highlights the growing diversity in the advertising industry.
The recognition from MM+M is valuable due to the publication's long-standing reputation in pharmaceutical marketing since 1966. Harper Ellsworth's approach combines creativity, strategic media placement, and insight-based strategies, proving effective across healthcare, consumer packaged goods, and automotive sectors. This nomination serves as an example of how creative marketing can play a crucial role in public health awareness, potentially saving lives through better communication of health information.
For more information about the 2024 MM+M Awards, interested parties can visit https://www.mmm-awards.com. To learn more about Harper Ellsworth and its services, visit www.HarperEllsworthAdvertising.com.
